Literature DB >> 25358000

Investigation of hFVIII production in mammary glands of transgenic mice.

Tahar Mohammadian1, Hossein Rassi.   

Abstract

Hemophilia A is an X-linked disorder affecting 1 in 10,000 males. The disease is caused by a defect or mutation of factor 8 or 9. Human factor 8 gene (hFVIII) is a relatively large gene consisting of 26 exons and approximately 2,351 amino acids with a length of 9 Kb mRNA. Expression of hFVIII in mammalian milk is becoming a widespread strategy for high-level production of hFVIII because of the most complex post-translational modifications. The aim of this study was the cloning and expression of hFVIII in mammary glands of two transgenic mice. To obtain a recombinant plasmid, first a plasmid carrying an FVIII gene fragment (pCMV6-hFVIII) was digested by EcoRI-SalI restriction enzymes and then the fragment was purified from agarose gel and inserted into a pUCWAP7 vector carrying a tissue-specific promoter (mWAP 4.1 kbp). After that, it was isolated by agarose gel and transferred into the murine zygotes by standard microinjection methods. Methods for expression of recombinant FVIII RT-PCR and ELISA were studied. The results show the successful expression of factor FVIII gene and its product in the mouse mammary glands.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25358000      PMCID: PMC4216513          DOI: 10.1089/mab.2014.0008

Source DB:  PubMed          Journal:  Monoclon Antib Immunodiagn Immunother        ISSN: 2167-9436


  17 in total

Review 1.  The hemophilias: progress and problems.

Authors:  P M Mannucci; E G Tuddenbam
Journal:  Semin Hematol       Date:  1999-10       Impact factor: 3.851

Review 2.  Blood proteins from transgenic animal bioreactors.

Authors:  H Luboń; R K Paleyanda; W H Velander; W N Drohan
Journal:  Transfus Med Rev       Date:  1996-04

3.  Complete cDNA and derived amino acid sequence of human factor V.

Authors:  R J Jenny; D D Pittman; J J Toole; R W Kriz; R A Aldape; R M Hewick; R J Kaufman; K G Mann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

Review 4.  Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders.

Authors:  W H Kane; E W Davie
Journal:  Blood       Date:  1988-03       Impact factor: 22.113

5.  Structure of human factor VIII.

Authors:  G A Vehar; B Keyt; D Eaton; H Rodriguez; D P O'Brien; F Rotblat; H Oppermann; R Keck; W I Wood; R N Harkins; E G Tuddenham; R M Lawn; D J Capon
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

6.  Molecular cloning of a cDNA encoding human antihaemophilic factor.

Authors:  J J Toole; J L Knopf; J M Wozney; L A Sultzman; J L Buecker; D D Pittman; R J Kaufman; E Brown; C Shoemaker; E C Orr
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

7.  Phenotypic and genotypic stability of multiple lines of transgenic pigs expressing recombinant human protein C.

Authors:  K E Van Cott; H Lubon; C G Russell; S P Butler; F C Gwazdauskas; J Knight; W N Drohan; W H Velander
Journal:  Transgenic Res       Date:  1997-05       Impact factor: 2.788

8.  Comparative study of the sugar chains of factor VIII purified from human plasma and from the culture media of recombinant baby hamster kidney cells.

Authors:  T Hironaka; K Furukawa; P C Esmon; M A Fournel; S Sawada; M Kato; T Minaga; A Kobata
Journal:  J Biol Chem       Date:  1992-04-25       Impact factor: 5.157

9.  Gene transfer efficiency during gestation and the influence of co-transfer of non-manipulated embryos on production of transgenic mice.

Authors:  R S Canseco; A E Sparks; R L Page; C G Russell; J L Johnson; W H Velander; R E Pearson; W N Drohan; F C Gwazdauskas
Journal:  Transgenic Res       Date:  1994-01       Impact factor: 2.788

10.  Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation.

Authors:  C Jhappan; A G Geiser; E C Kordon; D Bagheri; L Hennighausen; A B Roberts; G H Smith; G Merlino
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.